Heterocyclic compounds as hedgehog signaling pathway inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9579319
APP PUB NO 20160113928A1
SERIAL NO

14893691

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention relates to novel compounds of formula (I). The compounds of the invention are hedgehog pathway antagonists. Specifically, the compounds of the invention are useful as Smoothened (SMO) inhibitors. The invention also contemplates the use of the compounds for treating conditions treatable by the inhibition of the Hedgehog pathway and SMO, for example cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
REDX PHARMA PLCBLOCK 33F MERESIDE ALDERLEY PARK MACCLESFIELD SK10 4TG

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Armer, Richard Liverpool, GB 2 1
Bhamra, Inder Liverpool, GB 14 14
Bingham, Matilda Liverpool, GB 7 40
McCarroll, Andrew Liverpool, GB 1 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 28, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00